Federal Register / Vol. 60, No. 72 / Friday, April 14, 1995 / Notices 19065

Governors. Interested persons may

express their views in writing on the

question whether consummation of the

proposal can ‘‘reasonably be expected to

produce benefits to the public, such as

greater convenience, increased

competition, or gains in efficiency, that

outweigh possible adverse effects, such

as undue concentration of resources,

decreased or unfair competition,

conflicts of interests, or unsound

banking practices.’’ Any request for a

hearing on this question must be

accompanied by a statement of the

reasons a written presentation would

not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

Comments regarding the application

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than April 28, 1995.

A. Federal Reserve Bank of New

York (William L. Rutledge, Senior Vice

President) 33 Liberty Street, New York,

New York 10045:

1. The Royal Bank of Canada,

Montreal, Quebec, Canada; to expand

the geographic scope of its subsidiary,

RBC Dominion Securities Corporation,

New York, New York (Securities Corp.),

to operate on a worldwide basis.

Securities Corp., engages in securitiesrelated activities, including securities

brokerage actvities, as well as limited

securities underwriting and dealing. All

the activities have been previously

approved for this entity by order. See,

e.g. The Royal Bank of Canada, 77

Federal Reserve Bulletin 272 (1991).

Board of Governors of the Federal Reserve

System, April 10, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95-9211 Filed 4-13-95; 8:45 am]

BILLING CODE 6210-01-F

State Financial Services Corporation,

et al.; Formations of; Acquisitions by;

and Mergers of Bank Holding

Companies

The companies listed in this notice

have applied for the Board’s approval

under section 3 of the Bank Holding

Company Act (12 U.S.C. 1842) and §

225.14 of the Board’s Regulation Y (12

CFR 225.14) to become a bank holding

company or to acquire a bank or bank

holding company. The factors that are

considered in acting on the applications

are set forth in section 3(c) of the Act

(12 U.S.C. 1842(c)).

Each application is available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

application has been accepted for

processing, it will also be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing to the

Reserve Bank or to the offices of the

Board of Governors. Any comment on

an application that requests a hearing

must include a statement of why a

written presentation would not suffice

in lieu of a hearing, identifying

specifically any questions of fact that

are in dispute and summarizing the

evidence that would be presented at a

hearing.

Unless otherwise noted, comments

regarding each of these applications

must be received not later than May 8,

1995.

A. Federal Reserve Bank of Chicago

(James A. Bluemle, Vice President) 230

South LaSalle Street, Chicago, Illinois

60690:

1. State Financial Services

Corporation, Hales Corners, Wisconsin;

to acquire 100 percent of the voting

shares of Waterford Bancshares,

Waterford, Wisconsin, and thereby

indirectly acquire Waterford Bank,

Waterford, Wisconsin.

B. Federal Reserve Bank of St. Louis

(Randall C. Sumner, Vice President) 411

Locust Street, St. Louis, Missouri 63166:

1. Mercantile Bancorporation, Inc., St.

Louis, Missouri; to acquire 100 percent

of the voting shares of Southwest

Bancshares, Inc., Bolivar, Missouri, and

thereby indirectly acquire Southwest

Bank, Bolivar, Missouri.

Board of Governors of the Federal Reserve

System, April 10, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95-9212 Filed 4-13-95; 8:45 am]

BILLING CODE 6210-01-F

FEDERAL TRADE COMMISSION

[File No. 942 3052]

David Green, M.D.; Proposed Consent

Agreement With Analysis to Aid Public

Comment

AGENCY: Federal Trade Commission.

ACTION: Proposed consent agreement.

SUMMARY: In settlement of alleged

violations of federal law prohibiting

unfair acts and practices and unfair

methods of competition, this consent

agreement, accepted subject to final

Commission approval, would prohibit,

among other things, an individual doing

business as The Varicose Vein Center

from making various representations

about any vein treatment or cosmetic

surgery procedure he markets in the

future unless he possesses competent

and reliable scientific evidence to

substantiate the claims.

DATES: Comments must be received on

or before June 13, 1995.

ADDRESSES: Comments should be

directed to: FTC/Office of the Secretary,

Room 159, 6th St. and Pa. Ave., N.W.,

Washington, D.C. 20580.

FOR FURTHER INFORMATION CONTACT:

Richard Kelly or Sondra Mills, FTC/H–

200, Washington, D.C. 20580. (202) 326–

3304 or 326–2673.

SUPPLEMENTARY INFORMATION: Pursuant

to Section 6(f) of the Federal Trade

Commission Act, 38 Stat. 721, 15 U.S.C.

46 and § 2.34 of the Commission’s Rules

of Practice (16 CFR 2.34), notice is

hereby given that the following consent

agreement containing a consent order to

cease and desist, having been filed with

and accepted, subject to final approval,

by the Commission, has been placed on

the public record for a period of sixty

(60) days. Public comment is invited.

Such comments or views will be

considered by the Commission and will

be available for inspection and copying

at its principal office in accordance with

§ 4.9(b)(6)(ii) of the Commission’s Rules

of Practice (16 CFR 4.9(b)(6)(ii)).

Agreement Containing Consent Order to

Cease and Desist

In the matter of David Green, M.D., an

individual doing business as The Varicose

Vein Center, a sole proprietorship.

The Federal Trade Commission

having initiated an investigation of

certain acts and practices of David

Green, M.D., an individual doing

business as The Varicose Vein Center, a

sole proprietorship, and it now

appearing that David Green, M.D.,

sometimes referred to as proposed

respondent, is willing to enter into an

agreement containing an order to cease

and desist from the use of the acts and

practices being investigated,

It Is Hereby Agreed by and between

David Green, M.D., an individual doing

business as The Varicose Vein Center, a

sole proprietorship, and his attorney,

and counsel for the Federal Trade

Commission that:

1. Proposed respondent David Green,

M.D. (‘‘Dr. Green’’) is an individual

doing business as The Varicose Vein

Center, a sole proprietorship (‘‘VVC’’).

Respondent’s principal place of

business is located at 4800 Montgomery

Lane, Suite M50, in the City of

Bethesda, State of Maryland. Dr. Green

formulates, directs and controls the

policies, acts and practices of VVC.